Elicera Therapeutics
5.31 SEK
-2.39 %
Less than 1K followers
ELIC
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Elicera Therapeutics
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -2.7 | -2.9 | -16.9 | -8.1 | -2.9 | 0.2 | -7.1 | -17.9 |
| EBIT | -2.7 | -2.9 | -16.9 | -8.1 | -2.9 | 0.2 | -7.1 | -17.9 |
| EBIT-% | ||||||||
| Profit before taxes | -2.5 | -2.6 | -16.1 | -8.0 | -2.7 | 0.3 | -7.0 | -17.4 |
| Net income | -2.5 | -2.6 | -16.1 | -8.0 | -2.7 | 0.3 | -7.0 | -17.4 |